Cargando…
Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation
Background: The polio eradication endgame continues to increase in complexity. With polio cases caused by wild poliovirus type 1 and circulating vaccine-derived polioviruses of all three types (1, 2 and 3) reported in 2022, the number, formulation, and use of poliovirus vaccines poses challenges fo...
Autores principales: | Kalkowska, Dominika A, Wassilak, Steven GF, Wiesen, Eric, F Estivariz, Concepcion, Burns, Cara C, Badizadegan, Kamran, Thompson, Kimberly M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403636/ https://www.ncbi.nlm.nih.gov/pubmed/37547300 http://dx.doi.org/10.12688/gatesopenres.14511.1 |
Ejemplares similares
-
Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation
por: Thompson, Kimberly M., et al.
Publicado: (2023) -
Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
por: Thompson, Kimberly M., et al.
Publicado: (2019) -
Outbreak response strategies with type 2-containing oral poliovirus vaccines ()
por: Kalkowska, Dominika A., et al.
Publicado: (2023) -
Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas
por: Pedreira, Cristina, et al.
Publicado: (2017) -
Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016
por: Farrell, Margaret, et al.
Publicado: (2017)